Success Stories from the Scientists We Serve

“Axxam has revolutionized the limiting dilution process with the UP.SIGHT instrument over the past year. We experienced the power of this remarkable tool with its intuitive interface and double assurance of clonality, enabling us to accelerate the production of stable monoclonal cell lines expressing a diverse range of targets for our high-throughput screening campaigns.”

“UP.SIGHT is a very gentle and reliable cell dispensing system that allows for automation of assuredly monoclonal cell line generation with our very large and fragile protoplasts. The UP.SIGHT is easy to handle and easy to integrate into the existing lab due to its small footprint.”

“We can isolate one cell, one clone that has the exact desired genome, and we need to prove from a regulatory purpose that there is just one cell in any well. For this purpose, we selected the UP.SIGHT, where we make use of the double clonality assurance to be confident in the results

"Single cell efficacy: 70-93%; Colony efficacy: 58-91% (after optimization). The plating effort (to get single cells) can be lowered compared to limited dilution and FACS single cell deposition by the factor 4-5."

"When using the single-cell printer, the number of monoclonal cell lines increased 6-fold compared to the limiting dilution process, therefore increasing the number of pools that could be cloned. By implementing both of these technologies, the cell line development process can be decreased from 9 months to 6 months."

"ExcellGene SA relies on the Cytena Single Cell Dispenser, which offers both single cell dispensing and imaging capabilities. This technology provides documented evidence of clonality for all dispensed cells, ensuring the integrity and reliability of the resulting cell lines. The user-friendly nature of Cytena devices makes them invaluable tools for streamlining and optimizing laboratory workflows."